SHINE Technologies

Big tech's willingness to pay premium rates for clean energy is a powerful market signal. To meet their needs, we need to solve the nuclear energy cost equation. This isn't about incremental improvements -- it's about fundamentally rethinking how we approach nuclear development. First principles thinking and focused safety approaches can make both fission and fusion economically viable faster than many think. https://hubs.li/Q02Z3ccB0 #CleanEnergy #NuclearEnergy

Non-carrier-added lutetium-177 (n.c.a. Lu-177) is transforming cancer treatment, offering new hope for patients battling advanced prostate cancer and neuroendocrine tumors. Discover how this radioisotope works and why our innovative production methods are set to make this life-saving therapy more accessible than ever. https://hubs.li/Q02YHWLz0

Used nuclear fuel is an untapped energy resource. Our fusion-based approach could eliminate ~95% of nuclear waste streams while creating valuable materials for clean energy. Our CTO, Ross Radel, discusses the future of integrated fuel cycles on the panel "Saying Yes to the Fuel Cycle: Integrated Fuel Cycles, Creating an Experimental Prototype Community of Tomorrow" at the 2024 ANS Winter Conference and Expo on Nov. 19. https://hubs.li/Q02YmVWm0 #nuclearfuture #cleanenergy

We're seeing exciting progress at Chrysalis, soon to be the world's largest medical isotope production and irradiation facility. Every milestone brings us closer to producing millions of doses of life-saving cancer medicines right here in Wisconsin.

We're growing! We're looking for innovators and problem-solvers who are excited to revolutionize cancer treatment and advance fusion technology. Key openings include: Process Engineer (Fitchburg, WI) CGD Lab Technician- Part Time (Janesville, WI) Nuclear Quality Control Inspector (Janesville, WI) Senior I&C/ Electrical Engineer (Janesville, WI) Plus many more opportunities in engineering, finance, and operations across our Wisconsin facilities. Join us in creating a safer, healthier world through nuclear technology: https://hubs.li/Q02Y6bV30 #Hiring #NuclearJobs #NuclearMedicine #FusionJobs

Ross Radel, PhD, PE, Chief Technical Officer, recently presented on "Japan & the Path to Commercialization" at FusionX Group Invest: Japan 2024, an event focused on the growing fusion energy sector in Japan. This event brings together investors, technical innovators, and government influencers across all aspects of the fusion energy ecosystem.

From ensuring the reliability of military aircraft through neutron imaging to producing isotopes that can fight prostate cancer, our work touches the lives of service members past and present. On this Veterans Day, we're grateful for the 23 veterans on our team who continue to serve by advancing technologies that protect and heal.

Another great week of producing and shipping Ilumira (n.c.a. Lu-177) to support critical cancer research and treatments! When patients need treatment, every day matters.

Take a look inside Chrysalis, our state-of-the-art production facility under construction in Janesville, WI. As our founder and CEO Greg Piefer explains, it will be "the first major beneficial use of fusion to benefit humanity on a massive scale." Once complete, it will be the world's most flexible neutron irradiation source, and will boast a capacity of up to ~20 million doses of medicine every year. https://hubs.li/Q02T7lCJ0

When it comes to supporting the world’s need for nuclear medicine, one product shines bright. Ilumira, our n.c.a. Lu-177, offers unmatched radionuclidic purity and immediate worldwide shipping to bring life-saving medicine within reach like never before. Learn more about Ilumira by visiting our website. https://hubs.li/Q02VbXpy0